In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Abstract Submission Rules

ESC Congress 2020

Abstracts can only be submitted via the online abstract submission services. Abstracts sent by fax or email will not be accepted.

The submission deadline is Friday, 14 February 2020 - 12:00 noon Paris time. No further extension will be possible.

General Information

Draft status

If you do not click on the submit button (Step 4 of the abstract submission service), your abstract will be saved in draft status. You will then be able to review it and submit it at a later time (but only before the deadline).

N.B. Abstracts that are in draft status after the deadline cannot be processed and, therefore, will not be considered for selection.

Changes and corrections

Once submitted, it is not possible to make any corrections to the abstract content or information, such as authors' list and details, topics, conclusions, etc. The ESC is not authorised to make changes to a submission. In order to correct your abstract, you must withdraw it and submit a new corrected version prior to the deadline (see below for withdrawal procedure). Note that such replacement of your abstract is not possible after the deadline. In the case of errors in your abstract discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications. If accepted, your abstract will be published as submitted.


If you want to withdraw an abstract already submitted, please notify us as quickly as possible at stating the title and number of the abstract to be withdrawn.

Note that withdrawals are still accepted after the submission deadline, but abstracts may still appear in publications. All abstract withdrawal requests must be received in writing (via email) by June 2020 to avoid printed publications.  

 Step 1: Abstract Information


A maximum of 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title is not truncated if you copy and paste it into the field. Do not include authors, institutions, city names, trademarks and abbreviations in the title.


At the time of abstract submission, the submitter must select one single topic to index the abstract.

It is important to carefully select the best matching topic as this choice will determine under which area the abstract will be reviewed and graded.

Therefore, submitters should consider all potential options available before selecting the submission topic.

The topic list is organised by main topics and several layers of subtopics to maximise precision. An appropriate choice for the main topic and first subheadings is more important than your choice for the lowest layers of subtopics. 

If the abstract is accepted, the presenter will be required to select three additional topics/keywords. These are important to optimise indexing of the abstract in the programme and in the ESC 365 congress library. This serves to optimise search results and enhance the visibility of the research.

Note that in order to view the topic list, you must first select the ESC event for which you are submitting your abstract (first field of the page).


You must select one of the following categories under which your abstract can be best classified:

  • Bench: Animal studies or in vitro experiments at the molecular, cellular or tissue level (including human tissue). The core data is generated in the lab.
  • Bedside: Patient studies. The core data is generated during clinical studies or interventions.


You may choose to submit your abstract under one of the following options:  

Young Investigators Award (YIA) option

The following YIA sessions will be held during ESC Congress 2020:

  • Basic science 
  • Clinical cardiology
  • Thrombosis
  • Population sciences
  • Coronary pathophysiology and microcirculation

To present an abstract in one of the above YIA sessions, the first author/presenter must be under 40 years old at the time of presentation at the congress – i.e. born after 2 September 1980.

Special note to YIA submitters: If you are submitting the abstract on behalf of the first author/presenter, you must enter the first author’s date of birth because this date will be the qualifying point for the option validation. Abstracts with non-eligible dates of birth will be automatically removed from this option and graded as 'no option' abstracts. Please tick the appropriate box in the abstract information section. 

Nursing/Allied Professional Investigator Award option

Apply for the Nursing/Allied Professional Investigator Award, which is reserved for registered nurses and allied professionals within five years after confirmation of their PhDs. 

Note that by default the first author should be the presenter; if not, he/she needs to be able to explain his/her role in the research. Furthermore, presenters will be in competition and graded on site during the session under the following categories: originality, scientific content, presentation, and answers to questions. Therefore, they  need to speak English well.

If your abstract is selected for a YIA/NIA session, you will receive specific instructions. Prizes will be given during the Awards Ceremony to the four best presentations in each session (an award certificate and a prize of €2,000 for the winners; €1,000 for the runners-up).

We highlight the fact that only the presenter may have a prize and award certificate addressed to him/her.

Important! The first prize winners are expected to submit the full manuscript pertaining to the presented research for publication consideration.  YIA winners could be published in one of the ESC journals (European Heart Journal or Cardiovascular Research), while NIA winners could appear in the European Journal of Cardiovascular Nursing.

Please note that the manuscript should be uploaded by the winning author after presentation at the ESC Congress via the editorial manager and that this manuscript will undergo peer review (publication in one of the journals is not guaranteed).

On behalf of

You may use this field to enter the name of the affiliation for your research or the name of an investigating team. Do not use this field to list individual authors.

Affiliation/investigating teams will not be listed in the authors' index of the Scientific Programme, but will appear in publications.

Funding acknowledgements

All sources of financial support (including government grants) for this research must be filed under this heading and not in the abstract text. All grant funding agency abbreviations should be spelt out. This information will be published in the abstract itself.
The submitter is asked to indicate the type of funding source(s) and name it/them, if any.
This information may be used in the context of ESC research projects.


 Step 2: Abstract Authors and Institutions

Your abstract must list at least one author in order to be submitted.

Authors' list

Please note that the first author should be the abstract presenter by default. Nevertheless, it can be modified through the agreement form available online as of May 2020. In all cases, the presenter must be part of the authors' list included in the submitted abstract and be able to explain during the presentation his/her role in the research. You may enter up to 15 authors in the authors' list, including the presenter. If you have more than 15 authors, you can use the 'On behalf of' field (see above) to enter the name of an investigating team/study group.

The names of authors will be published as listed on the submission form. Please make sure you have entered the full list of authors - official contributors in the research submitted - and that the information given for each author is correct because no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).
The authors’ order and details (names, cities, country codes) will be published, as entered by the submitter.

The submitter certifies and warrants to the ESC that the list of authors is complete and that he/she has permission from all persons he/she enters as co-authors to be listed in this abstract and that they are aware that their names will appear in all publications.

If none of the authors is able to present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered as a 'no-show' and the ESC Congress Programme Committee can then decide not to consider an abstract submitted by the same author the following year.


This is a mandatory step.

You will be requested to select your institution when you create the presenter and the authors. Once you have entered your city, a list will automatically appear from which you can select your institution.

If your institution is not on the list, you have the possibility of creating it.

If your city is not on the list, please enter it, press 'enter's, and then add your institution.

 Step 3: Abstract Content

All abstracts must be submitted (and will be presented) in English using UK English spelling with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker, by a university scientific publications office (or another similar facility) prior to submission.

Abstracts must contain original material neither published nor presented elsewhere (in print or electronically) prior to ESC Congress 2020.

Abstracts submitted on animal studies  must follow the 'principles of laboratory animal care' (NIH Publication No. 85-23, revised 1985),  according to the national law, if applicable.

Do not cut and paste symbols into your text. Use the symbols provided when you click on the omega button (Ω).

We recommend you structure your abstract using the following headings:

  • Background/Introduction
  • Purpose
  • Methods
  • Results
  • Conclusion(s)

There is not a specific maximum of words, but rather a maximum total size for the abstracts (shown as 100%), including the text with spaces and tables (if any). The maximum abstract size is 35 lines (3,000 characters).

Use the 'save' and 'refresh' buttons at the bottom in order to display the size of the abstract in percentage terms (shown on the left of the screen). The programme converts the size into a percentage when you save it as a draft.
The character limit does not include the title and authors. Only the abstract text, tables and spaces are taken into account.

Abstract table

The table field holds a table without surrounding text. Do not copy your table into the field. You must recreate your table using the tools provided.

The maximum size of the table is 12 columns and 20 rows, and you can only enter one table. The title field is optional.

In addition to your text, you can add a picture.

Abstract picture

Your picture file must meet the following criteria:

  • Format: jpeg or GIF
  • Size: less than 1 MB
  • Measures no larger than 800 pixels(x) x 600 pixels(y)

Please make sure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.

Important: As the grading and selection process is blind, the title and body text must not contain identifying features, i.e. information such as:

  • Names (authors or others)
  • Names of the institutes (hospitals, medical schools, clinics…)
  • Cities

Also not authorised

  • Trademarks. The use of commercial drug names, brands and registered trademarks is strictly prohibited. Instead, use generic drug names. Drugs should be referred to by their active substances or pharmacological designations.
  • Company names and locations.
  • Websites and email addresses.

Failure to comply with the above requirements will/may lead to automatic rejection of the submission, or this information may be deleted by the abstract services, and some rephrasing may occur.

Furthermore, the Abstract Reviewing Committee (graders) is required to identify abstracts that pertain to the commercial promotion of a proprietary product and to notify the selection committee.  

Do not include grant acknowledgements in the abstract content. Use the appropriate field.

Do not cite keywords or references in the abstract, as they are not allowed and will be deleted.

Do not include copyright or trademark symbols.

Limit the use of acronyms and abbreviations. Define at first use with an acronym or abbreviation in parentheses.

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association. We remind you that the patient’s photo should be not be used, and the patient must never be identifiable in your presentation.

 Step 4: Abstract Preview and Submission

Proofread abstracts carefully to avoid errors before submission, check spelling and grammar. The abstract will be reviewed and published (if accepted) as it has been submitted – No Exceptions!

Do not forget to click on the 'submit' button to validate your abstract submission. After having submitted your abstract, you will receive an immediate automatic confirmation by email (please make sure to state your correct email address!) notifying you of the abstract number. Please use this reference in all correspondence. If you do not receive this confirmation, please contact the Abstract Team.

There is no limit to the number of abstracts an author/individual may submit, but the same research cannot be submitted twice, even under a different topic/category or with a different title. If you submit two abstracts with the same content, the Abstract Submission Service will automatically keep the most recent abstract submitted and withdraw the other. Note that duplicate draft abstracts will not be deleted.

If you have difficulties in submitting your abstracts or if you need any further information, please contact the Abstract Team.

 Abstract grading/results

All abstracts are blind and will be reviewed by seven to 10 members of the Abstract Reviewing Committee (graders). Each grader is selected by the ESC Congress Programme Committee to review abstracts in the category that best fits their expertise.

Our intent is to be most inclusive of the quality science received without compromising scientific integrity.

The Abstract Reviewing Committee (graders) is required to identify abstracts that pertain to the commercial promotion of a proprietary product and to notify the selection committee.

Abstracts submitted for consideration must be an original idea, concept, or an improvement or revision of a previous idea. Submissions are peer-reviewed for scientific content, logical presentation, and current interest of the topic to the scientific community.

In April 2020, the final selection will be made by the ESC Congress Programme Committee, which will determine the format, day and time of presentation for each abstract. No rescheduling or changes will be possible.

Accepted abstracts will be scheduled either as oral presentations or Moderated Poster or half-day Poster Presentations.

All presentations will include questions and answers conducted in English. Presenters are expected to speak good English.

All abstract submitters will be notified by email in early May 2020 about the outcome (accepted or not accepted) of the review-and-selection process.  Please ensure that the email provided is accurate because all correspondence will be sent via email.

If the abstract is accepted, instructions and guidelines concerning the abstract presentation will be provided online.  

The same presenter cannot be assigned to more than three abstracts - co-authors should then be assigned as presenters.

All expenses (airfare, hotel...) associated with the submission and presentation of an abstract are the responsibility of the presenter.

No-show policy

Submission of an abstract constitutes a formal commitment by the author(s) to present the work, if accepted. Failure to present and register for the congress, if not justified (withdrawn), will be identified as a 'no-show' and will jeopardize future acceptance of abstracts. In addition, abstracts identified as 'no-shows' will be removed from all congress publications (including ESC 365).

 Publication of abstracts

All presented abstracts will be published in the abstract supplement of the European Heart Journal – Volume 41, September 2020.


Accepted abstracts are under embargo until one week before the congress. At that time they will be available on ESC 365 via the Scientific Programme & Planner and also on the ESC 2020 Mobile App.

Abstracts selected for an ESC press release will remain under embargo until the beginning of the session in which they are presented. Abstract content will be released thereafter.

Until presentation at ESC Congress 2020, accepted abstracts should not be published in any other journals and/or online publications or presented at any international congresses.

Breaking of the embargo policy by a presenter or co-author will lead to:

  • Withdrawal of their presentation from the ESC press conference and/or scientific session
  • Retraction from all ESC publications
  • Prohibition against submitting abstracts at any ESC congresses for one year

Affirmation of originality and copyright transfer statement

By submitting your work to the ESC:

  • You consent to have authors’ names, affiliations and biographical material used in connection with the publication of your work.
  • Author(s) represents and warrants to the ESC that he/she/they is/are the sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.
    The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders and that all statements declared as facts are based on thorough examination and investigation for accuracy.
  • Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, previous presentation at national meetings and/or non-cardiovascular specialists meetings does not disqualify.
    A submitter, presenter or co-author submitting or presenting previously published work will lead to:
    • Withdrawal of their presentation from the press conference and/or scientific session.
    • Prohibition against submitting abstracts to any ESC congresses for one year.
    • Their submitting abstracts that must report new information not previously published or presented at a national or international scientific meeting prior to the congress. Note that abstracts previously presented at meetings will not be accepted unless there is a substantial update of data.
  • Identified duplicates will be retracted from all related ESC publications.
  • The content belongs to the author(s). However, if the abstract is accepted, the submitter agrees, on behalf of all co-authors, to transfer and assign to the ESC free of charge on a non-exclusive basis – for 15 years from the present submission – the rights to edit, publish, reproduce, reformat, distribute in whole or in part the abstract and to prepare all types of derivative works, such as press releases and/or educational products, using all communication tools and means, now known or hereinafter developed, including any and all digital means and any and all supports or forms of media now known or hereinafter developed, in particular all paper, analog, digital, numerical and electronic media, including Internet, Intranet and Extranet sites and social media. This includes use in indexes or search databases in print, electronic, or other media.

Author(s) retain the right, after presentation at the congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of the ESC.

The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.

Conflict of interest

The ESC Congress Programme Committee requests that all presenters display a slide at the beginning of their presentations (at the bottom of the poster for Poster Presentations) indicating disclosure information for themselves and all co-authors, as applicable, or to indicate that they have nothing to disclose. Please state 'none' if no conflicts exist.

This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationships, etc.
All potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors or being publicly associated with a company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees, or receiving grants or funds from such corporations or individuals representing such corporations.

Data privacy

By certifying that you have read these submission rules, you also confirm having received the prior approval from your co-authors to provide their data to the ESC.

The information collected in this Call for Abstracts is subject to data processing for the elaboration of the ESC Congress 2020 Abstract-Based Programme.

Provision of personal data is a statutory requirement to list authors who have contributed to the research submitted. Authors not listed in the submission will not be acknowledged in the abstract and promotion of the abstract – if accepted for publication and presentation at the congress.

Recipients of the data are ESC staff who process the submissions and the ESC committees and volunteers involved in the Abstract–Based Programme.

Data collected will be kept for 20 years.

Transfer of personal data to ESC staff, contractors, as well as to other ESC-related scientific organisations occurs for production, promotion and dissemination of the congress content.

In accordance with Chapter 3 of the European Regulation 2016/679 with regards to data protection, you have the right to request from the ESC access to – and rectification or erasure of – your personal data or restriction of processing concerning your data,  including the right to data portability. This can be done through the withdrawal of the abstract, according to the terms and conditions of withdrawal.

For such, please contact (be aware that a proof of identity will be requested during the process via a secure web link).

You have the right to lodge a complaint with a supervisory authority. For information, the ESC has appointed a data protection officer you can reach at

Applicable law

All the rules pertaining to the present submission are governed by, and construed in accordance with, the laws of France without regard to any conflicts of laws principles thereof that would require the application of the law of any other jurisdiction. Any disputes arising in relation hereto shall be submitted to the exclusive jurisdiction of the French Tribunal de Grande Instance located in Grasse, France.


Go to the submission page